September 06, 2025

Get In Touch

Tata Trusts, Assam Govt To Invest Rs 1400 Crore For Cancer Care Grid

Guwahati Cancer Research Centre

Guwahati: Upcoming Cancer Research Centre and Care Grid

A South Asian cancer research centre and a three-level cancer care grid is likely to come up in Assam soon.

This was revealed by Assam Health Minister Dr. Himanta Biswa Sharma, following his meeting with Ratan Tata and members of Tata Trusts in Mumbai last evening.

The ventures would be a philanthropy-government collaboration between the government of Assam and Tata Trusts, the minister said.

"Government of Assam and Tata Trusts are working on setting up a unique, first-of-its-kind 3-level cancer care grid at state, capital, and district levels which is likely to have an investment of ₹1400 crore and proposed to be shared between Tata Trusts and the state," Dr. Sharma said.

Under the grid system:

  • L1 or state level cancer care institute at Guwahati to have advanced, tertiary care facilities.
  • L2 or medical college to have chemo, radiation, and surgical oncology.
  • L3 or district hospitals to have day care, chemotherapy, and radiation facilities.

"A South Asian Cancer Research centre is also proposed to be set up to undertake research on identifying reasons and develop treatment protocols with a focus on South Asia," Dr. Sharma revealed further.

He added that final announcements in these respects are expected to be made by Tata Trusts soon.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!